Skip to main content

Psoriatic arthritis

      RT @doctorRBC: Lower ILD incidence in PsA than RA in a large Nordic registry
      ⭐️ No significant ⬆️ in ILD in tho
      3 years 7 months ago
      Lower ILD incidence in PsA than RA in a large Nordic registry ⭐️ No significant ⬆️ in ILD in those using MTX Abs#OP0222 #EULAR2021 @RheumNow https://t.co/lgGhu1Hmd6
      RT @MeralElRamahiMD: Key points on phenotypes in PsA per Dr. Dafna Gladman:

      ⭐️Oligoarticular & polyarticular Ps
      Key points on phenotypes in PsA per Dr. Dafna Gladman: ⭐️Oligoarticular & polyarticular PsA pts have the same burden of dz ⭐️Dactylitis assoc w/ greater dz severity & US synovitis + erosive changes in DMARD-naive early PsA pts #EULAR2021 @RheumNow
      RT @ARD_BMJ: #EULAR2021 Gender differences in chronic #arthritis 🙋🙋‍♂️

      ▶️ POS1061: The Italian prospect
      3 years 7 months ago
      #EULAR2021 Gender differences in chronic #arthritis 🙋🙋‍♂️ ▶️ POS1061: The Italian prospective SIRENA study: women do worse at the onset of #psoriaticarthritis 🇮🇹 ▶️ POS0208: The Austrian Registry BIOREG: women showed lower response rates to #TNFi 🇦🇹 > LA https://t.co/JNxrqimp2Y
      RT @RichardPAConway: Dr Deodhar on upadacitinib in axial PsA. Appears to be effective in combined analysis of SELECT-PsA
      3 years 7 months ago
      Dr Deodhar on upadacitinib in axial PsA. Appears to be effective in combined analysis of SELECT-PsA 1 and 2. @RheumNow #EULAR2021 Abstr#0233 https://t.co/fBMWVb3oBd
      RT @doctorRBC: Israeli study of all cause mortality in PsA vs general population
      ⭐️no increased mortality in PsA gro
      3 years 7 months ago
      Israeli study of all cause mortality in PsA vs general population ⭐️no increased mortality in PsA group ⭐️leading causes of death was cancer in both groups ⭐️age, male sex, BMI, socioeconomic status, PsO associated with ⬆️mortality, NOT DMARDs Abs#OP0219 #EULAR2021 @RheumNow
      RT @doctorRBC: Metabolomic profiling for PsA showed vLDL, triglycerides; apolipoprotein B, glycoprotein acetylene associ
      3 years 7 months ago
      Metabolomic profiling for PsA showed vLDL, triglycerides; apolipoprotein B, glycoprotein acetylene associated with increased CV events… Do you monitor cholesterol levels in your PsA pts? Abs#OP0221 #EULAR2021 @RheumNow
      RT @doctorRBC: What does this graph represent to you? To me: we have a whole lot of PsA that all work equally well..
      Itâ
      3 years 7 months ago
      What does this graph represent to you? To me: we have a whole lot of PsA that all work equally well.. It’s time for more personalized approach to PsA treatment! Excellent talk by @DrLauraCoates Abs#OP6937 #EULAR2021 @RheumNow https://t.co/1NKLfmH2y5
      RT @doctorRBC: Similar efficacy of PsA enthesitis treatment between adalimumab and secukinumab
      ⭐️mean change and res
      3 years 7 months ago
      Similar efficacy of PsA enthesitis treatment between adalimumab and secukinumab ⭐️mean change and resolution of enthesitis similar ⭐️resolution of equal but ⬇️ in pts with ⬆️ baseline enthesitis activity ⭐️rate of relapse ⬇️ and similar Abs#POS0194 #EULAR2021 @RheumNow https://t.co/uPE4kmotCY
      RT @doctorRBC: Interesting small study on US assessment of Achilles of PsA vs normal pts after exercise
      ⭐️significan
      3 years 7 months ago
      Interesting small study on US assessment of Achilles of PsA vs normal pts after exercise ⭐️significant different of PD signal in PsA group ⭐️5 non-PsA pts still had PD🤔 Would be interesting to further classify differences in PD intensity… Abs#POS1058 #EULAR2021 @RheumNow https://t.co/SLhqq4wgCl
      ×